KEY HIGHLIGHTS
- Net profit USD 44 Mn in 2Q26, -23.2% QoQ, taking 1H26 to USD 102 Mn: 55.5% of FY26F consensus, a beat, while 1H26 revenue is only 41.3%, a miss.
- 2Q26 revenue USD 782 Mn, +121.9% YoY, as MBMA segment revenue rose 29.9% QoQ to USD 590 Mn on higher HGNM sales and USD 83 Mn of acid sales. Pani added USD 28 Mn in its first full quarter.
- 2Q26 gross margin 27.7%, -7.4pp QoQ, as only USD 2 Mn of cost went into inventory against USD 94 Mn in 1Q26, and royalties rose 59% QoQ under the new HPM benchmark. A USD 40 Mn FX loss hit 2Q26 profit.
- Our read: a solid half, a softer quarter. 1H26 profit is ahead of consensus, but 2Q26 profit fell as NPI cash margin halved and minorities took 53%. At 6.3x forward EV/EBITDA, below the -1SD of 8.5x, the market doubts the 2H26 that consensus still needs. Key watch: whether Pani’s 2H26 output reaches the 83,000-98,000 oz its guidance implies.
Regards, Aldiracita Research